{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:44:38Z","timestamp":1793051078007,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020737","name":"Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.biomaterials.2026.124396","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:19:23Z","timestamp":1781911163000},"page":"124396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Programmable multivalent aptamer-drug conjugates enable stable tumor targeting and enhanced therapy for advanced bladder cancer"],"prefix":"10.1016","volume":"335","author":[{"given":"Shan","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiping","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haige","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6313-3500","authenticated-orcid":false,"given":"Haozhi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biomaterials.2026.124396_bib1","article-title":"Consensus and controversy in advanced urologic cancers: insights from the advanced urologic cancer consensus conference (AUC3) 2025","volume":"76","author":"Jang","year":"2026","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124396_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41585-024-00904-9","article-title":"Optimizing cystoscopy and TURBT: enhanced imaging and artificial intelligence","volume":"22","author":"Shkolyar","year":"2025","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124396_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","article-title":"European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines","volume":"85","author":"Alfred Witjes","year":"2024","journal-title":"Eur. Urol."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124396_bib4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41585-025-01072-0","article-title":"Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies","volume":"22","author":"Wen","year":"2025","journal-title":"Nat. Rev. Urol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124396_bib5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.eururo.2024.07.027","article-title":"European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-a summary of the 2024 guidelines update","volume":"86","author":"Gontero","year":"2024","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124396_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","article-title":"Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice","volume":"20","author":"van Hoogstraten","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124396_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41585-024-00963-y","article-title":"Metastasis development in non-muscle-invasive bladder cancer","volume":"22","author":"Leyderman","year":"2025","journal-title":"Nat. Rev. Urol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124396_bib8","first-page":"165","article-title":"Antibody-drug conjugates: smart chemotherapy delivery across tumor histologies","volume":"72","author":"Tarantino","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124396_bib9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2312117","article-title":"Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer","volume":"390","author":"Powles","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124396_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1200\/JCO.22.01643","article-title":"Enfortumab vedotin plus pembrolizumab in previously untreated advanced urothelial cancer","volume":"41","author":"Hoimes","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124396_bib11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41392-024-01973-3","article-title":"Aptamer-drug conjugates-loaded bacteria for pancreatic cancer synergistic therapy","volume":"9","author":"Xiao","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"23","key":"10.1016\/j.biomaterials.2026.124396_bib12","doi-asserted-by":"crossref","first-page":"8559","DOI":"10.1021\/jacs.1c03013","article-title":"Regulating the anticancer efficacy of sgc8-combretastatin A4 conjugates: a case of recognizing the significance of linker chemistry for the design of aptamer-based targeted drug delivery strategies","volume":"143","author":"Huang","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124396_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41571-023-00850-2","article-title":"Exploring the next generation of antibody-drug conjugates","volume":"21","author":"Tsuchikama","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.biomaterials.2026.124396_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202425252","article-title":"DNA framework-ensembled aptamers enhance fluid stability in circulating tumor cells capture for tumor treatment evaluation","volume":"64","author":"Chen","year":"2025","journal-title":"Angew. Chem.-Int. Edit."},{"key":"10.1016\/j.biomaterials.2026.124396_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115646","article-title":"From cell-SELEX to tissue-SELEX for targeted drug delivery and aptamer nanomedicine","volume":"224","author":"Wong","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4968","key":"10.1016\/j.biomaterials.2026.124396_bib16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science"},{"issue":"6287","key":"10.1016\/j.biomaterials.2026.124396_bib17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In vitro selection of RNA molecules that bind specific ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"issue":"28","key":"10.1016\/j.biomaterials.2026.124396_bib18","doi-asserted-by":"crossref","first-page":"15459","DOI":"10.1002\/anie.202102631","article-title":"Enhancing anti-PD-1 immunotherapy by nanomicelles self-assembled from multivalent aptamer drug conjugates","volume":"60","author":"Geng","year":"2021","journal-title":"Angew. Chem.-Int. Edit."},{"key":"10.1016\/j.biomaterials.2026.124396_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2024.126092","article-title":"Surface-enhanced Raman scattering-based identification of breast cancer progression using extracellular vesicles-derived integrin \u03b16\u03b24","volume":"275","author":"Lei","year":"2024","journal-title":"Talanta"},{"key":"10.1016\/j.biomaterials.2026.124396_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115685","article-title":"Aptamers as target-specific recognition elements in drug delivery","volume":"226","author":"Egbe Vydaline","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"20","key":"10.1016\/j.biomaterials.2026.124396_bib21","doi-asserted-by":"crossref","first-page":"7998","DOI":"10.1073\/pnas.1220817110","article-title":"Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics","volume":"110","author":"Zhu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124396_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2024.110804","article-title":"Enhancing the stability of 68Ga-labeled RNA aptamers for pancreatic \u03b2-cell and insulinoma imaging through nucleoside modifications","volume":"36","author":"Li","year":"2025","journal-title":"Chin. Chem. Lett."},{"issue":"45","key":"10.1016\/j.biomaterials.2026.124396_bib23","doi-asserted-by":"crossref","first-page":"30911","DOI":"10.1021\/acsnano.4c07969","article-title":"The emerging era of molecular medicine","volume":"18","author":"Tang","year":"2024","journal-title":"ACS Nano"},{"issue":"17","key":"10.1016\/j.biomaterials.2026.124396_bib24","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.7150\/thno.115496","article-title":"Aptamer-based drug delivery for targeted therapy of imatinib-resistant gastrointestinal stromal tumor","volume":"15","author":"Pan","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2026.124396_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123502","article-title":"Amplifying tumor recognition and drug susceptibility by multivalent ApDC assembly to combat with tumor cell heterogeneity","volume":"324","author":"Wang","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124396_bib26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.omtn.2016.11.008","article-title":"Aptamer-drug conjugates of active metabolites of nucleoside analogs and cytotoxic agents inhibit pancreatic tumor cell growth","volume":"6","author":"Yoon","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biomaterials.2026.124396_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115692","article-title":"Aptamers as a new frontier in targeted cancer therapy","volume":"226","author":"Li","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"22","key":"10.1016\/j.biomaterials.2026.124396_bib28","doi-asserted-by":"crossref","first-page":"12471","DOI":"10.1021\/acs.chemrev.3c00377","article-title":"Aptamer-protein interactions: from regulation to biomolecular detection","volume":"123","author":"Ji","year":"2023","journal-title":"Chem. Rev."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124396_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrd.2016.199","article-title":"Aptamers as targeted therapeutics: current potential and challenges","volume":"16","author":"Zhou","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"37","key":"10.1016\/j.biomaterials.2026.124396_bib30","doi-asserted-by":"crossref","first-page":"9728","DOI":"10.1016\/j.biomaterials.2013.08.079","article-title":"A polyvalent aptamer system for targeted drug delivery","volume":"34","author":"Zhang","year":"2013","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124396_bib31","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1021\/acs.nanolett.5c06019","article-title":"A universal framework nucleic acid platform for kidney-targeted delivery of natural bioactive compounds","volume":"26","author":"Sun","year":"2026","journal-title":"Nano Lett."},{"issue":"14","key":"10.1016\/j.biomaterials.2026.124396_bib32","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1021\/jacs.3c00841","article-title":"Aptamer-based targeted delivery of functional nucleic acids","volume":"145","author":"Xie","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124396_bib33","doi-asserted-by":"crossref","first-page":"12035","DOI":"10.1021\/acs.chemrev.0c01140","article-title":"Aptamer-based detection of circulating targets for precision medicine","volume":"121","author":"Wu","year":"2021","journal-title":"Chem. Rev."},{"issue":"45","key":"10.1016\/j.biomaterials.2026.124396_bib34","first-page":"24506","article-title":"Covalent LYTAC enabled by DNA aptamers for immune checkpoint degradation therapy","volume":"145","author":"Li","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"22","key":"10.1016\/j.biomaterials.2026.124396_bib35","doi-asserted-by":"crossref","first-page":"8391","DOI":"10.1021\/jacs.1c02016","article-title":"Aptamer-based logic computing reaction on living cells to enable non-antibody immune checkpoint blockade therapy","volume":"143","author":"Yang","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"37","key":"10.1016\/j.biomaterials.2026.124396_bib36","doi-asserted-by":"crossref","first-page":"43359","DOI":"10.1021\/acsami.3c07344","article-title":"Self-assembled multivalent aptamer drug conjugates: enhanced targeting and cytotoxicity for HER2-positive gastric cancer","volume":"15","author":"Ma","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124396_bib37","doi-asserted-by":"crossref","first-page":"17257","DOI":"10.1021\/acsnano.1c08036","article-title":"Engineering DNA on the surface of upconversion nanoparticles for bioanalysis and therapeutics","volume":"15","author":"Zhang","year":"2021","journal-title":"ACS Nano"},{"issue":"43","key":"10.1016\/j.biomaterials.2026.124396_bib38","doi-asserted-by":"crossref","first-page":"15275","DOI":"10.1073\/pnas.0407024101","article-title":"Triggered amplification by hybridization chain reaction","volume":"101","author":"Dirks","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"29","key":"10.1016\/j.biomaterials.2026.124396_bib39","doi-asserted-by":"crossref","first-page":"11892","DOI":"10.1002\/anie.202004206","article-title":"In situ synthesis of an aptamer-based polyvalent antibody mimic on the cell surface for enhanced interactions between immune and cancer cells","volume":"59","author":"Shi","year":"2020","journal-title":"Angew. Chem.-Int. Edit."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124396_bib40","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJMoa2035807","article-title":"Enfortumab vedotin in previously treated advanced urothelial carcinoma","volume":"384","author":"Powles","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.biomaterials.2026.124396_bib41","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1039\/C8CS00676H","article-title":"Cleavable linkers in antibody-drug conjugates","volume":"48","author":"Bargh","year":"2019","journal-title":"Chem. Soc. Rev."},{"issue":"49","key":"10.1016\/j.biomaterials.2026.124396_bib42","doi-asserted-by":"crossref","first-page":"19430","DOI":"10.1021\/acs.analchem.4c03914","article-title":"Utilizing DNA logic device for precise detection of circulating tumor cells via high catalytic activity au nanoparticle anchoring","volume":"96","author":"Guo","year":"2024","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124396_bib43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2025.08.008","article-title":"Aptamer-based positron emission tomography imaging allows specific detection of residual bladder cancer: a first-in-human study","volume":"89","author":"Ding","year":"2026","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124396_bib44","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/s41467-021-21587-5","article-title":"DNA stability: a central design consideration for DNA data storage systems","volume":"12","author":"Matange","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124396_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2026.118710","article-title":"Bifunctional DNA multivalent structure integrating stable capture of urothelial carcinoma cells with CRISPR\/Cas12a signal amplification for bladder cancer detection","volume":"306","author":"Sun","year":"2026","journal-title":"Biosens. Bioelectron."},{"issue":"23","key":"10.1016\/j.biomaterials.2026.124396_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202100837","article-title":"Proteomic exploration of endocytosis of framework nucleic acids","volume":"17","author":"Tian","year":"2021","journal-title":"Small"},{"issue":"30","key":"10.1016\/j.biomaterials.2026.124396_bib47","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.1002\/anie.201403236","article-title":"Single-particle tracking and modulation of cell entry pathways of a tetrahedral DNA nanostructure in live cells","volume":"53","author":"Liang","year":"2014","journal-title":"Angew. Chem.-Int. Edit."},{"issue":"27","key":"10.1016\/j.biomaterials.2026.124396_bib48","doi-asserted-by":"crossref","first-page":"24335","DOI":"10.1021\/acsnano.5c03945","article-title":"Framework nucleic acid nanomaterials for central nervous system therapies: design for barrier penetration, targeted delivery, cellular uptake, and endosomal escape","volume":"19","author":"Chen","year":"2025","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124396_bib49","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41392-025-02399-1","article-title":"An aptamer-drug conjugate for promising cancer therapy with comprehensive evaluation from rodents to non-human primates","volume":"10","author":"Su","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124396_bib50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41421-024-00667-y","article-title":"LncRNA TubAR complexes with TUBB4A and TUBA1A to promote microtubule assembly and maintain myelination","volume":"10","author":"Liang","year":"2024","journal-title":"Cell Discov."},{"key":"10.1016\/j.biomaterials.2026.124396_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119494","article-title":"Visible light-induced apoptosis activatable nanoparticles of photosensitizer-DEVD-anticancer drug conjugate for targeted cancer therapy","volume":"224","author":"Um","year":"2019","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124396_bib52","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat. Rev. Cancer"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226004205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226004205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:04:22Z","timestamp":1785906262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226004205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":52,"alternative-id":["S0142961226004205"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124396","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Programmable multivalent aptamer-drug conjugates enable stable tumor targeting and enhanced therapy for advanced bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124396"}}